Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bahareh Estiri"'
Autor:
Akbar Farjadfar, Mohammad Estiri, Bahareh Estiri, Asghar Fallah, Marziyeh Aghazadeh, Amir Sedaqati, Abbas Abdollahi, Mahsa Rabienia, Nahid Mortazavidehkordi
Publikováno v:
Current gene therapy. 22(5)
Background: Cancer-related anemia (CRA) negatively influences cancer patients’ survival, disease progression, treatment efficacy, and quality of life (QOL). Current treatments such as iron therapy, red cell transfusion, and erythropoietin-stimulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776dc5bd7c55154ff7930a68816f205b
https://pubmed.ncbi.nlm.nih.gov/35382717
https://pubmed.ncbi.nlm.nih.gov/35382717
Autor:
Nahid Mortazavidehkordi, Asghar Fallah, Bahareh Estiri, Marzyeh Aghazadeh, Mohammad Estiri, Mohammad Ghorbani, Mahsa Rabienia, Akbar Farjadfar, Amir Sedaqati, Abbas Abdollahi
Cancer-related anemia (CRA) negatively influences cancer patients’ survival, disease progression, treatment efficacy, and quality of life (QOL). Current treatments such as iron therapy, red cell transfusion, and erythropoietin-stimulating agents (E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc650566701a4fdc5f2c0ab3b057299
https://doi.org/10.21203/rs.3.rs-84099/v3
https://doi.org/10.21203/rs.3.rs-84099/v3
Autor:
Mohammad Estiri, Bahareh Estiri, Asghar Fallah, Marzyeh Aghazadeh, Amir Sedaqati, Abbas Abdollahi, Mahsa Rabienia, Nahid Mortazavidehkordi, Akbar Farjadfar
BackgroundCancer-related anemia (CRA) negatively influences cancer patients’ survival, disease progression, treatment efficacy, and quality of life (QOL). Current treatments such as iron therapy, red cell transfusion, and erythropoietin-stimulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0af234d3ac7c1be8748d122446fb03d9
https://doi.org/10.21203/rs.3.rs-84099/v1
https://doi.org/10.21203/rs.3.rs-84099/v1
Autor:
Ali Fallah, Abbas Abdollahi, Akbar Farjadfar, Zahra Ghayour Najafabadi, Vahid Kia, Bahareh Estiri, Nahid Mortazavidehkordi, Hossein Khanahmad, Nooshin Hashemi, Zahra Roudbari, Ali Najafi, Seyed Hossein Hejazi
Publikováno v:
Parasitology research. 117(7)
Hydrophilic acylated surface protein B (HASPB) is an immunogenic Leishmania-specific protein that antibodies are produced against it in the sera of Leishmania-infected individuals. Kinetoplastid membrane protein 11 (KMP11) is another Leishmania antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fef70f0261f070b513a62707b4f3425
https://pubmed.ncbi.nlm.nih.gov/29845415
https://pubmed.ncbi.nlm.nih.gov/29845415